Genetic Signatures Limited (ASX:GSS) Might Not Be As Mispriced As It Looks After Plunging 30%
Apr 11
Have your own idea? Try our Stock Screener
Australian (ASX) Life Sciences Industry Analysis
UpdatedApr 14, 2025
DataAggregated Company Financials
Companies8
- 7D-2.5%
- 3M-29.4%
- 1Y-32.5%
- YTD-34.5%
No data
Industry Valuation and Performance
Has the Australian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 14 Apr 2025 | AU$420.9m | AU$272.6m | -AU$65,041,866.00 | 14.4x | -6.5x | 1.5x |
| Wed, 12 Mar 2025 | AU$450.3m | AU$272.6m | -AU$65,041,866.00 | 14.1x | -6.9x | 1.7x |
| Fri, 07 Feb 2025 | AU$518.7m | AU$253.8m | -AU$57,118,384.00 | 16.2x | -9.1x | 2x |
| Sun, 05 Jan 2025 | AU$656.7m | AU$263.5m | -AU$69,135,603.00 | 21.3x | -9.5x | 2.5x |
| Tue, 03 Dec 2024 | AU$593.8m | AU$263.5m | -AU$69,135,603.00 | 19.3x | -8.6x | 2.3x |
| Thu, 31 Oct 2024 | AU$682.1m | AU$263.5m | -AU$69,135,603.00 | 23.4x | -9.9x | 2.6x |
| Sat, 28 Sep 2024 | AU$728.3m | AU$263.3m | -AU$69,597,222.00 | 23.5x | -10.5x | 2.8x |
| Mon, 26 Aug 2024 | AU$638.6m | AU$246.7m | -AU$49,718,118.00 | 23x | -12.8x | 2.6x |
| Wed, 24 Jul 2024 | AU$636.7m | AU$246.1m | -AU$49,506,434.00 | 28.2x | -12.9x | 2.6x |
| Fri, 21 Jun 2024 | AU$570.4m | AU$246.1m | -AU$49,506,434.00 | 26.1x | -11.5x | 2.3x |
| Sun, 19 May 2024 | AU$550.0m | AU$246.1m | -AU$49,506,434.00 | 18.9x | -11.1x | 2.2x |
| Tue, 16 Apr 2024 | AU$584.6m | AU$246.1m | -AU$49,506,434.00 | 16.1x | -11.8x | 2.4x |
| Thu, 14 Mar 2024 | AU$551.5m | AU$246.1m | -AU$49,506,434.00 | 13.1x | -11.1x | 2.2x |
| Sat, 10 Feb 2024 | AU$490.4m | AU$248.2m | -AU$39,797,313.00 | 22.5x | -12.3x | 2x |
| Mon, 08 Jan 2024 | AU$462.4m | AU$248.2m | -AU$39,797,313.00 | 21.1x | -11.6x | 1.9x |
| Wed, 06 Dec 2023 | AU$565.5m | AU$248.6m | -AU$52,451,569.00 | 19.1x | -10.8x | 2.3x |
| Fri, 03 Nov 2023 | AU$545.0m | AU$248.6m | -AU$52,451,569.00 | 22.5x | -10.4x | 2.2x |
| Sun, 01 Oct 2023 | AU$562.9m | AU$248.6m | -AU$52,451,569.00 | 22.5x | -10.7x | 2.3x |
| Tue, 29 Aug 2023 | AU$603.9m | AU$221.4m | -AU$37,799,687.00 | 22.5x | -16x | 2.7x |
| Thu, 27 Jul 2023 | AU$660.4m | AU$221.5m | -AU$37,611,177.00 | 25.2x | -17.6x | 3x |
| Sat, 24 Jun 2023 | AU$658.7m | AU$221.5m | -AU$37,611,177.00 | 24.6x | -17.5x | 3x |
| Mon, 22 May 2023 | AU$635.7m | AU$221.5m | -AU$37,611,177.00 | 28.7x | -16.9x | 2.9x |
| Wed, 19 Apr 2023 | AU$677.4m | AU$221.5m | -AU$37,611,177.00 | 28.3x | -18x | 3.1x |
| Fri, 17 Mar 2023 | AU$714.7m | AU$221.7m | -AU$39,169,534.00 | 29x | -18.2x | 3.2x |
| Sun, 12 Feb 2023 | AU$783.4m | AU$184.6m | -AU$29,264,632.00 | 33.5x | -26.8x | 4.2x |
| Tue, 10 Jan 2023 | AU$795.1m | AU$184.6m | -AU$29,264,632.00 | 34.2x | -27.2x | 4.3x |
| Thu, 08 Dec 2022 | AU$776.3m | AU$184.6m | -AU$29,264,632.00 | 31.4x | -26.5x | 4.2x |
| Sat, 05 Nov 2022 | AU$767.8m | AU$184.6m | -AU$29,264,632.00 | 29.6x | -26.2x | 4.2x |
| Mon, 03 Oct 2022 | AU$809.5m | AU$184.6m | -AU$29,264,632.00 | 32.7x | -27.7x | 4.4x |
| Wed, 31 Aug 2022 | AU$887.8m | AU$173.8m | -AU$30,247,610.00 | 49.4x | -29.4x | 5.1x |
| Fri, 29 Jul 2022 | AU$865.1m | AU$150.4m | -AU$31,222,532.00 | 27.4x | -27.7x | 5.8x |
| Sun, 26 Jun 2022 | AU$826.1m | AU$150.4m | -AU$31,222,532.00 | 27.6x | -26.5x | 5.5x |
| Tue, 24 May 2022 | AU$1.0b | AU$150.2m | -AU$30,481,316.00 | 31x | -33.3x | 6.7x |
| Thu, 21 Apr 2022 | AU$1.2b | AU$150.2m | -AU$30,481,316.00 | 20.8x | -39.9x | 8.1x |
Price to Earnings Ratio
-39.9x
Current Industry PENo data
Past Earnings GrowthNo data
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | 0.085% | |
| Healthcare | -3.67% | |
| Life Sciences | -2.53% | |
| Clinical Research and Equipment | -2.53% | |
Industry PENo data
Forecasted GrowthNo data
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VFY Vitrafy Life Sciences | AU$1.23 | 13.9% +AU$9.6m | n/a | PB2.3x | |
| PIQ Proteomics International Laboratories | AU$0.47 | 16.0% +AU$8.5m | -58.8% | PS17.6x | |
| EZZ EZZ Life Science Holdings | AU$1.45 | 10.7% +AU$6.6m | 70.6% | PE7.6x | |
| CTE Cryosite | AU$0.80 | 5.3% +AU$2.0m | 15.2% | PE21.2x | |
| TRJ Trajan Group Holdings | AU$0.75 | 1.4% +AU$1.5m | -39.0% | PS0.7x |
